Katherine A. Guthrie, Ph.D.
Affiliations: | 2001 | University of Washington, Seattle, Seattle, WA |
Area:
Biostatistics BiologyGoogle:
"Katherine Guthrie"Parents
Sign in to add mentor| Elizabeth A. Sheppard | grad student | 2001 | University of Washington | |
| (A hierarchical aggregate data model with allowance for spatially correlated disease rates.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Magaret AS, Jacob ST, Halloran ME, et al. (2020) Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions. Annals of Internal Medicine |
| Gibson CJ, Huang AJ, Larson JC, et al. (2020) Patient-Centered Change in the Day-to-Day Impact of Postmenopausal Vaginal Symptoms: Results from a Multicenter Randomized Trial. American Journal of Obstetrics and Gynecology |
| Sohal D, Duong MT, Ahmad SA, et al. (2020) SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA). Journal of Clinical Oncology. 38: 4504-4504 |
| Meyerhardt JA, Shi Q, Fuchs CS, et al. (2020) Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702. Journal of Clinical Oncology. 38: 4003-4003 |
| Iqbal S, McDonough S, Lenz HJ, et al. (2019) Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of : SWOG S1201. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900925 |
| Guthrie KA, Caan B, Diem S, et al. (2019) Facebook advertising for recruitment of midlife women with bothersome vaginal symptoms: A pilot study. Clinical Trials (London, England). 1740774519846862 |
| Sohal D, McDonough S, Ahmad SA, et al. (2019) SWOG S1505: Initial findings on eligibility and neoadjuvant chemotherapy experience with mfolfirinox versus gemcitabine/nab-paclitaxel for resectable pancreatic adenocarcinoma. Journal of Clinical Oncology. 37: 414-414 |
| Diem SJ, Guthrie KA, Mitchell CM, et al. (2018) Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause (New York, N.Y.) |
| Mitchell CM, Reed SD, Diem S, et al. (2018) Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. Jama Internal Medicine |
| Ramanathan RK, McDonough S, Philip PA, et al. (2018) A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139). Journal of Clinical Oncology. 36: 208-208 |